Atropine Sulfate Hydrate Reagent Market In Global
Atropine sulfate monohydrate is a competitive antagonist for the muscarinic acetylcholine recept ... Read More
Atropine sulfate is a competitive nonselective antagonist at central and peripheral muscarinic acetylcholine receptors. This medication is used before eye examinations and to treat certain eye conditions. It belongs to a class of drugs known as anticholinergics.
This report contains market size and forecasts of Atropine Sulfate Hydrate API in global, including the following market information:
Global Atropine Sulfate Hydrate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atropine Sulfate Hydrate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Atropine Sulfate Hydrate API companies in 2021 (%)
The global Atropine Sulfate Hydrate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atropine Sulfate Hydrate API include C²PHARMA, Seqens, Clearsynth, Katsura Chemical, Cfm Oskar Tropitzsch, CarboMer, Wuhan Fortuna Chemical, IsunPharm and Capot Chemical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atropine Sulfate Hydrate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Sulfate Hydrate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Atropine Sulfate Hydrate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Atropine Sulfate Hydrate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Atropine Sulfate Hydrate API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Atropine Sulfate Hydrate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Atropine Sulfate Hydrate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atropine Sulfate Hydrate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atropine Sulfate Hydrate API revenues share in global market, 2021 (%)
Key companies Atropine Sulfate Hydrate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Atropine Sulfate Hydrate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
C²PHARMA
Seqens
Clearsynth
Katsura Chemical
Cfm Oskar Tropitzsch
CarboMer
Wuhan Fortuna Chemical
IsunPharm
Capot Chemical
Atropine sulfate monohydrate is a competitive antagonist for the muscarinic acetylcholine recept ... Read More
Edoxaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor.
... Read More
Edoxaban is an oral factor Xa (FXa) inhibitor, also contraindicated in patients with active patho ... Read More
Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.
This re ... Read More